These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3912181)

  • 1. Susceptibility to tobramycin determined by a modified agar dilution method with a high inoculum.
    Santanam P
    Eur J Clin Microbiol; 1985 Dec; 4(6):600-1. PubMed ID: 3912181
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of the disk diffusion test to detect tobramycin resistance in kanamycin-resistant Escherichia coli strains.
    Santanam P
    J Clin Microbiol; 1984 Aug; 20(2):295-7. PubMed ID: 6092419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overproduction of 3'-aminoglycoside phosphotransferase type I confers resistance to tobramycin in Escherichia coli.
    Menard R; Molinas C; Arthur M; Duval J; Courvalin P; Leclercq R
    Antimicrob Agents Chemother; 1993 Jan; 37(1):78-83. PubMed ID: 8381641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
    Juhlin I; Tunevall G
    Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
    Drugeon HB; Courtieu AL
    Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activity of tobramycin against gram-negative bacteria and the combination of ampicillin/tobramycin against E. coli.
    Laxer RM; Mackay E; Marks MI
    Chemotherapy; 1975; 21(2):90-8. PubMed ID: 168040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
    Schassan HH
    Infection; 1976; 4(2):35-41. PubMed ID: 789246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isomeric DNA ladder formation of a plasmid encoding tobramycin resistance from Escherichia coli.
    Singh M; John JF
    J Antimicrob Chemother; 1991 Nov; 28(5):627-37. PubMed ID: 1685732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro drug sensitivity tests with Kanendomycin and Tobramycin].
    Béla E; Béla K
    Orv Hetil; 1976 Sep; 117(37):2239-41. PubMed ID: 967429
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of oxygen limitation in the resistance of agar-entrapped, sessile-like Escherichia coli to aminoglycoside and beta-lactam antibiotics.
    Tresse O; Jouenne T; Junter GA
    J Antimicrob Chemother; 1995 Sep; 36(3):521-6. PubMed ID: 8830016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid development of resistance of gentamicin, tobramycin and amikacin by E. coli 07.
    Humble MW; Bettelheim KA
    N Z Med J; 1978 May; 87(612):366. PubMed ID: 353599
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications.
    Dulong de Rosnay HL; Grimont PA; Dessaut B; Lesgouarres MT
    J Infect Dis; 1976 Aug; 134 Suppl():S50-6. PubMed ID: 823279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R plasmids coding for gentamicin, tobramycin, and carbenicillin resistance in Serratia, Klebsiella and Escherichia coli strains from a single clinical source.
    Knothe H; Kettner M; Kopsová D; Krcméry V
    Chemotherapy; 1977; 23(1):37-43. PubMed ID: 401718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple method for determining bacterial susceptibility to aminoglycosides.
    Hinchliffe PM; Robertson L; Farrell ID; Kirkwood BR
    J Med Microbiol; 1977 Aug; 10(3):381-7. PubMed ID: 408495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of gram-negative bacteria to six aminoglycoside antibiotics.
    Eyckmans L; Beert J
    Infection; 1977; 5(1):9-12. PubMed ID: 404254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.
    Moellering RC; Wennersten C; Kunz LJ; Poitras JW
    Am J Med; 1977 Jun; 62(6):873-81. PubMed ID: 868901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bactericidal activity of aminosides in a static system and in a dynamic model].
    Drugeon HB; Maurisset B; Courtieu AL
    Nouv Presse Med; 1979 Oct; 8(42):3403-6. PubMed ID: 395504
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro susceptibility of clinically important bacteria to amikacin: correlation of results of broth dilution and disk sensitivity tests and effect of medium composition.
    Linzenmeier G; Naumann P; Neussel H; Rosin H
    J Infect Dis; 1976 Nov; 134 SUPPL():S262-70. PubMed ID: 825584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of strains of enteropathogenic Escherichia coli to tobramycin and other antibiotics.
    Konforti N; Lev B; Hanner N
    Med Microbiol Immunol; 1977 Dec; 163(4):269-76. PubMed ID: 342889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the in vitro activity of tobramycin and gentamicin against 6,042 clinical isolates.
    Melby K; Midtvedt T; Dahl O
    Chemotherapy; 1979; 25(5):286-95. PubMed ID: 113179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.